XEDEV is a CRO/CDMO specialised in formulation and process development for solid dosage forms.
XEDEV has the capabilities to develop early phase formulations up to clinical phase for different administration routes.

XEDEV offers:
– formulation and process development of drug products via drying, granulation, tableting and coating processes
– different analytical tools to characterize drug substances and products (e.g. solid state, powder/tablet characterization, assay and purity analysis)
– clincial batch productions up to phase IIb

Type of Drugs Manufactured:

Small Molecule;Biologics

CDMO Services:

Drug Product Formulation (FDF);Research & Development

No. of Manufacturing Facilities:

1

High Potent Products capabilities:

OEB 3;OEB 4-5

Facilities Locations:

Europe

Regulatory Approvals for facilities:

EMA (Europe)

Manufacturing Technologies:

Inhalers;Solids

Company Products and Services:

CMO/CDMO

Current Capacity:

Our lead times to start new projects are 4-6 weeks.